期刊文献+

肾移植后并发糖尿病的危险因素及治疗 被引量:5

Risk factors and treatment for diabetes mellitus after kidney transplantation
下载PDF
导出
摘要 背景:肾移植后并发糖尿病是肾移植治疗后常见的并发症之一。目的:探讨肾移植后并发糖尿病的危险因素以及临床治疗。方法:应用数据库文献检索的方法获取肾移植后并发糖尿病研究的文献,对符合研究标准的文献进行深入的数据分析,文章选取肾移植后并发糖尿病的危险因素进行深入分析,并总结国内外关于肾移植后并发糖尿病的治疗方法。结果与结论:肾移植后并发糖尿病是由多种因素作用而引起的糖代谢异常,肾移植后并发糖尿病与患者年龄、体质量指数、血脂水平、免疫抑制剂方案、急性排斥发生频率、糖皮质激素累积等因素相关。在肾移植后定期检测血糖变化,可以较早的发现糖尿病的发生,通过中西医药物降低血糖和调整免疫抑制剂等方法可以有效治疗。 BACKGROUND: Diabetes mellitus is a common complication after kidney transplantation. OBJECTIVE: To investigate the risk factors for diabetes mellitus after kidney transplantation diabetes mellitus risk factors and clinical treatment based on integrative medicine. METHODS: Literatures concerning diabetes mellitus after kidney transplantation were retrieved in the database, and the articles that met the study criteria were analyzed. In this paper, we analyzed the risk factors for diabetes mellitus and concluded the therapies for diabetes mellitus after kidney transplantation. RESULTS AND CONCLUSION: Diabetes meUitus after kidney transplantation is an abnormal glucose metabolism caused by multiple factors, which is related to age, body mass index, lipid levels, immunosuppressantprogram, frequency of acute rejections, and cumulative dose of glucocorticoid. Periodic monitoring of blood glucose after kidney transplantation contributes to the earlier detection of the occurrence of diabetes mellitus. Integrative medicines that can lower blood glucose level and immunosuppressant adjustment can be effective for the treatment of diabetes mellitus after kidney transplantation.
出处 《中国组织工程研究》 CAS CSCD 2013年第44期7803-7808,共6页 Chinese Journal of Tissue Engineering Research
基金 河北省中医药管理局资助项目(2012068)~~
关键词 器官移植 器官移植学术探讨 肾移植 糖尿病 危险因素 免疫抑制剂 糖皮质激素 环孢素A 他克莫 治疗 预防 省级基金 organ transplantation kidney transplantation diabetes mellitus diabetes mellitus, type 2 hypoglycemic drugs
  • 相关文献

参考文献24

  • 1王滨,张涌,陈泽涛.CD36与2型糖尿病研究进展[J].中华临床医师杂志(电子版),2013,7(1):127-128. 被引量:2
  • 2Cosio FG,Pesavento TE,Kim S. Patient survival after renal transplantation:IV.Impact of post-transplant diabetes[J].{H}Kidney International,2002,(04):1440-1446.
  • 3Yoshida EM,Buczkowski AK,Sirrs SM. Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents:a case series[J].{H}Transplant International,2000,(01):69-72.
  • 4Wilkinson A,Davidson J,Dotta F. Guidelines for the treatment and management of new-onset diabetes after transplantation[J].{H}Clinical Transplantation,2005,(03):291-298.
  • 5Medline. Pubmed[DB/OL].http://www.ncbi.nlm.nih.gov/pubmed/,2013.
  • 6中国知网.中国学术期刊总库[DB/OL],https://wwwcnkinet,2013.
  • 7Cosio FG,Pesavento TE,Pel etier RP. Patient survival after renal transplantation III:the effects of statins[J].{H}American Journal of Kidney Disease,2002,(03):638-643.
  • 8Kasiske BL,Snyder JJ,Gilbertson D. Diabetes mel itus after kidney transplantation in the United States[J].{H}AMERICAN JOURNAL OF TRANSPLANTATION,2003,(02):178-185.
  • 9柯德叶?吐尔逊.肾移植后糖尿病的临床特点分析及患病因素探讨[M]新疆:新疆医科大学,20075-9.
  • 10Panz VR,Bonegio R,Raal FJ. Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1[J].{H}TRANSPLANTATION,2007,(04):587-590.

二级参考文献49

  • 1Robert Heine.餐后高血糖的临床意义[J].国际内分泌代谢杂志,2006,26(3). 被引量:25
  • 2刘洪涛,彭龙开,谢续标,贺志军.肾移植术后糖尿病的治疗[J].医学临床研究,2006,23(9):1391-1393. 被引量:4
  • 3王振,高江平,罗芸,卢锦山,敖建华,肖序仁,洪宝发,石炳毅,薛毅珑.不同浓度他克莫司在体外对胰岛的毒性作用及致糖尿病作用的临床研究[J].中华器官移植杂志,2006,27(11):681-684. 被引量:15
  • 4王振,石炳毅,高江平,罗芸.免疫抑制剂对人胰岛细胞的毒性作用[J].解放军医学杂志,2007,32(1):43-45. 被引量:3
  • 5Matas A J, Gillingham K J, Humar A, et al. Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome [ J ]. Transplantation, 2008, 85 (3) :338-343.
  • 6Hjelmesaeth J, Asberg A, MUller F, et al. New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection [J]. Curt Diabetes Rev, 2005, 1(1) :1-10.
  • 7Ekstrand AV, Eriksson JG, Gronhagen-Riska C, et al. Insulin resistance and insulin deficiency in the pathogenesis of postt-ransplantation diabetes in man [ J ]. Transplantation, 1992, 53 (3) :563-569.
  • 8Midtvedt K, Hartmann A, Hjelmesath J, et al. Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplantrecipients [J]. Nephrol Dial Transplant, 1998, 13(2):427-431.
  • 9Shimizu M, Iino Y, Terashi A. Improvement of insulin sensitivity after renal transplantation measured by a glucose clamp technique [J]. Nippon Ika Daigaku Zasshi, 1998, 65 (1) : 50 -54.
  • 10Araki M, Flechner SM, Ismail HR, et al. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs [ J ]. Transplantation, 2006, 81 (3) :335-341.

共引文献15

同被引文献49

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8229
  • 2SHARIF A, BABOOLAL K. Risk factors for new-onset diabetes after kidney transplantation[J]. Nat Rev Nephrol, 2010, 6(7): 415 -423.
  • 3HUR KY, KMI MS, KMI YS, et al. Risk factors associated with the onset and progression of post transplantation diabetes in re- nalal lograft recipients[J]. Diabetes Care, 2007, 30: 609-615.
  • 4HOSSEINI MS, NEMATI E, POURFARIZIANI V, et al. Early hyperglycemia after allogenic kidey transplantation: dose it induce infections [J]. Ann transplant, 2007, 12(4): 23.
  • 5BALLA A, CHOBANIAN M. New-onset diabetes after transplan- tation: a review of recent literature[J]. Curt Opin Organ Trans- plant, 2009, 14(4): 375-379.
  • 6VALLON V, THOM SON. Renal function in diabetic disease modds: the tubular system in the pathophysiology of the diabetic kidney [J]. Annu Rev Physiol, 2012, 74: 351-375.
  • 7ISAKA Y, SUZUKI C, ABE T, et al. Bc122 protects tubularep- ithelial cells from ischemia/reperfusion injury by dual mecha- nisms[J]. Transplant Proc, 2009, 41(1): 52-54.
  • 8YANAMADALA V, NEGORO H, DENKER BM. Heterotrimeric gproteins and apoptosis inter secting signaling path ways leading to context dependent phenotypes[J]. Curt Mol Med, 2009, 9(5): 527-545.
  • 9Buttgereit F, Dunstan CR, Gundberg C, et al. Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism[ J]. J Clin Invest, 2012,122( 11 ) : 4172-4189.
  • 10Song IH, Buttgereit F. Non-genomic glucocorticoid effect to pro- vide the basis for new drug developments [ J ]. Mol Cell Eudocri- nol, 2006,246(1-2) :142-146.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部